- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Pharmaceutical Contract Manufacturing and Contract market will register a 6.6% CAGR in terms of revenue, the global market size will reach $ 97680 million by 2025, from $ 75530 million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmaceutical Contract Manufacturing and Contract business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Pharmaceutical Contract Manufacturing and Contract market by type, application, key companies and key regions.
This study considers the Pharmaceutical Contract Manufacturing and Contract value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Oral
Injectable
API
Other
The proportion of API Manufacturing in 2018 is about 73%, and the proportion is in decreasing trend from 2014 to 2018. However, the Injectable segment is the fastest growing segment.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Small Medium Enterprise
Large Enterprise
The most proportion of pharmaceutical contract manufacturing & contract is used for Large Enterprise, and the proportion in 2018 is 60%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Catalent
Nipro Corp
Thermo Fisher Scientific
Boehringer Ingelheim
Fareva
Lonza
AbbVie
Recipharm
Baxter
Aenova
Mylan
Zhejiang Hisun
Dr. Reddy’s
Sopharma
Shandong Xinhua
Vetter
Jubilant
Piramal
Famar
Zhejiang Huahai
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pharmaceutical Contract Manufacturing and Contract market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Pharmaceutical Contract Manufacturing and Contract market by identifying its various subsegments.
Focuses on the key global Pharmaceutical Contract Manufacturing and Contract players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmaceutical Contract Manufacturing and Contract with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pharmaceutical Contract Manufacturing and Contract submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size 2015-2025
2.1.2 Pharmaceutical Contract Manufacturing and Contract Market Size CAGR by Region
2.2 Pharmaceutical Contract Manufacturing and Contract Segment by Type
2.2.1 Oral
2.2.2 Oral
2.2.3 API
2.2.4 Other
2.3 Pharmaceutical Contract Manufacturing and Contract Market Size by Type
2.3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Market Share by Type (2015-2020)
2.3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type (2015-2020)
2.4 Pharmaceutical Contract Manufacturing and Contract Segment by Application
2.4.1 Small Medium Enterprise
2.4.2 Large Enterprise
2.5 Pharmaceutical Contract Manufacturing and Contract Market Size by Application
2.5.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Market Share by Application (2015-2020)
2.5.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Application (2015-2020)
3 Global Pharmaceutical Contract Manufacturing and Contract by Players
3.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Players (2018-2020)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size Market Share by Players (2018-2020)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Manufacturing and Contract by Regions
4.1 Pharmaceutical Contract Manufacturing and Contract Market Size by Regions
4.2 Americas Pharmaceutical Contract Manufacturing and Contract Market Size Growth
4.3 APAC Pharmaceutical Contract Manufacturing and Contract Market Size Growth
4.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size Growth
4.5 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size Growth
5 Americas
5.1 Americas Pharmaceutical Contract Manufacturing and Contract Market Size by Countries
5.2 Americas Pharmaceutical Contract Manufacturing and Contract Market Size by Type
5.3 Americas Pharmaceutical Contract Manufacturing and Contract Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pharmaceutical Contract Manufacturing and Contract Market Size by Regions
6.2 APAC Pharmaceutical Contract Manufacturing and Contract Market Size by Type
6.3 APAC Pharmaceutical Contract Manufacturing and Contract Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract by Countries
7.2 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract by Countries
8.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Type
8.3 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pharmaceutical Contract Manufacturing and Contract Market Forecast
10.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Forecast (2021-2025)
10.2 Global Pharmaceutical Contract Manufacturing and Contract Forecast by Regions
10.2.1 Global Pharmaceutical Contract Manufacturing and Contract Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pharmaceutical Contract Manufacturing and Contract Forecast by Type
10.8 Global Pharmaceutical Contract Manufacturing and Contract Forecast by Application
11 Key Players Analysis
11.1 Catalent
11.1.1 Company Details
11.1.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Catalent News
11.2 Nipro Corp
11.2.1 Company Details
11.2.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.2.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Nipro Corp News
11.3 Thermo Fisher Scientific
11.3.1 Company Details
11.3.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.3.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Thermo Fisher Scientific News
11.4 Boehringer Ingelheim
11.4.1 Company Details
11.4.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Boehringer Ingelheim News
11.5 Fareva
11.5.1 Company Details
11.5.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Fareva News
11.6 Lonza
11.6.1 Company Details
11.6.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.6.3 Lonza Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Lonza News
11.7 AbbVie
11.7.1 Company Details
11.7.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.7.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 AbbVie News
11.8 Recipharm
11.8.1 Company Details
11.8.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.8.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Recipharm News
11.9 Baxter
11.9.1 Company Details
11.9.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Baxter News
11.10 Aenova
11.10.1 Company Details
11.10.2 Pharmaceutical Contract Manufacturing and Contract Product Offered
11.10.3 Aenova Pharmaceutical Contract Manufacturing and Contract Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Aenova News
11.11 Mylan
11.12 Zhejiang Hisun
11.13 Dr. Reddy’s
11.14 Sopharma
11.15 Shandong Xinhua
11.16 Vetter
11.17 Jubilant
11.18 Piramal
11.19 Famar
11.20 Zhejiang Huahai
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Pharmaceutical Contract Manufacturing and Contract Market Size CAGR by Region 2015-2025 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
